Dare Bioscience (DARE) Return on Equity [ROE] (2017 - 2026)
Dare Bioscience (DARE) recorded Return on Equity [ROE] of -1046.14% in Q2 2026.
Powered by 
Analysis
Dare Bioscience (DARE) Return on Equity [ROE] (2017 - 2026) Analysis & Trends
For FY2023, Dare Bioscience reported Return on Equity [ROE] of -1020.37%, down 894.49 percentage points from FY2022.
- Annual Return on Equity [ROE] has a five-year change of -851.71 percentage points (FY2018 to FY2023).
- Across earlier years, Return on Equity [ROE] came in at -125.88% in FY2022 (+81.92 pp), -207.80% in FY2021 and -400.28% in FY2019 (-231.62 pp).
- The Q2 2026 figure is the lowest quarterly Return on Equity [ROE] since Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,127.42 Bn | 1,096.00 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 633.77 Bn | 553.63 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 505.19 Bn | 478.30 Bn | 12.70 Bn | - |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 290.00 Bn | 253.99 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 265.19 Bn | 238.88 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 238.02 Bn | 193.42 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.79 Bn | 168.99 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 171.11 Bn | 117.76 Bn | 10.94 Bn | 4.97% |
| 10 | Dare Bioscience | 9.92 Mn | -55.55 Mn | -132,343.00 | -1,046.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,046.14% |
| Dec 31, 2025 | -474.68% |
| Sep 30, 2024 | -3,935.18% |
| Jun 30, 2023 | -3,617.92% |
| Mar 31, 2023 | -390.06% |
| Dec 31, 2022 | -167.59% |
| Sep 30, 2022 | -83.19% |
| Jun 30, 2022 | -94.59% |
| Mar 31, 2022 | -114.24% |
| Dec 31, 2021 | -110.61% |
| Sep 30, 2021 | -191.59% |
| Jun 30, 2021 | -597.68% |
| Mar 31, 2021 | -2,928.24% |
| Jun 30, 2020 | -1,058.55% |
| Mar 31, 2020 | -849.02% |
| Dec 31, 2019 | -1,274.64% |
| Sep 30, 2019 | -390.03% |
| Jun 30, 2019 | -285.35% |
| Mar 31, 2019 | -233.90% |
| Dec 31, 2018 | -207.02% |
API Access
Dare Bioscience Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "DARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();